Literature DB >> 21460809

Prostate cancer: Synergistic sequential enhancement of docetaxel.

Suzanne J Farley.   

Abstract

Entities:  

Year:  2011        PMID： 21460809     DOI： 10.1038/nrurol.2010.236

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

1.  Histone deacetylase inhibitor potentiates anticancer effect of docetaxel via modulation of Bcl-2 family proteins and tubulin in hormone refractory prostate cancer cells.

Authors:  Jung Jin Hwang; Yong Sook Kim; Mi Joung Kim; Dong Eun Kim; In Gab Jeong; Choung-Soo Kim
Journal:  J Urol       Date:  2010-10-28       Impact factor: 7.450

2.  Synergistic antimicrotubule therapy for prostate cancer.

Authors:  Vaishali Pannu; Prasanthi Karna; Hari Krishna Sajja; Deep Shukla; Ritu Aneja
Journal:  Biochem Pharmacol       Date:  2010-11-16       Impact factor: 5.858
  2 in total
  1 in total

1.  Biodistribution and Efficacy of Low Temperature-Sensitive Liposome Encapsulated Docetaxel Combined with Mild Hyperthermia in a Mouse Model of Prostate Cancer.

Authors:  Ashish Ranjan; Compton J Benjamin; Ayele H Negussie; Saurin Chokshi; Paul H Chung; Dmitry Volkin; Nitin Yeram; W Marston Linehan; Matthew R Dreher; Peter A Pinto; Bradford J Wood
Journal:  Pharm Res       Date:  2016-06-24       Impact factor: 4.200
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.